Connect with us

Health

Prostrate cancer: Foundation commences awareness through creative art

Published

on

Medicaid Cancer Foundation (MCF), a Non-Governmental Organisation (NGO), has initiated a synergy with local artistes to create awareness in the fight against prostate cancer.

The News Agency of Nigeria (NAN) reports that the move was aimed at sensitising the men folks from 40 years and above about the dangers of the cancer, the funding and the treatment.

NAN reports that the event was a collaboration between Johnson and Johnson (J&J) Innovative Medicine and Maigaskiya Visuals, tagged, “Art 4 Cancer”.

Dr Zainab-Shinkafi Bagudu, the Founder of the foundation described the work of Art as major communication tool for the fight against the scourge of the disease.

Through Art, he said that emotions, ideas, and innovative ideas can be employed as strategy to mobilise the people for the better understanding of the dangerous effect of the decease.

Bagudu, a former first lady of Kebbi State, identified lack of effective communication tool for mobilisation of the citizen in advocacy as a major impediment.

She, however, noted that one of the dynamic strategies to educate the is the mobilisation of artistes to convey messages for effectiveness.

According to her, the foundation decided to move the crowd out of their homes to raise fund for cancer patients by using the talent of the creative artists to express concern about cancer.

“Art is a way of expressing different emotions, different ideas and different innovations. One of the biggest problems that we have in cancer advocacy is how to get the message across to the people.

“The important thing is for us to know that cancer is real; it is killing over 20 million people across the world every year, and 80 per cent of these people are from the lower and middle cadre, so we have to educate ourselves about it.

ALSO READ:  UBEC; Collaborating National, Multinationals to Improve Basic Education

“We need to accept preventive measures; we need to adopt a healthy lifestyle; no smoking! no alcohol!! and then exercise regularly. These are some of the things that are important to prevent it.

“Another key to this is that early detection is the key to saving lives,” Bagudu maintained.

Mr Joshua Ochogwu, Programme Manager, MCF, said that “Art 4 Cancer” was designed by the Foundation to reduce the culture of silence, emphasising the evil effect of prostate cancer to the society.

He said that art has the power of reviving, uniting and bringing people together, and showed his appreciation for the large turnout of scores of creative artistes at the programme.

“We have visual artists here, young creative minds, musical artists, poets and we have photographers, among others.

“It is a passion for us, it is something we believe it will create more awareness about cancer.

“A lot of our art photography have been sold already, depicting photographs on cancer.

“No man can stand and fight cancer alone, we can only stand together to fight it and see the success,” he said.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health

NAFDAC clarifies position on importation of anti-leprosy drugs

Published

on

The National Agency for Food and Drug Administration and Control (NAFDAC), has emphasised its commitment to due process in the importation of Rifampicin, an anti-leprosy drug, into Nigeria.

NAFDAC’s Director-General, Prof. Mojisola Adeyeye, explained the agency’s position on the matter in a statement on Monday.

She was responding to a BBC report titled “Vital leprosy drugs due in Nigeria after year delay”.

The report had suggested that NAFDAC had either delayed or prevented the importation of essential leprosy treatment.

Adeyeye explained that before any drug could be imported into Nigeria, it must undergo rigorous testing, laboratory checks, and compliance with regulatory requirements.

“This was the case with Rifampicin, the medicine in question, which NAFDAC was accused of delaying.

“The BBC report also highlighted a request from the World Health Organisation (WHO) for NAFDAC to lift its new testing policy to expedite the importation of the medicine.”

Adeyeye clarified that her response was aimed at providing accurate information and dispelling any misinformation circulating regarding the agency’s actions.

NAFDAC, Adeyeye recalled, was established to safeguard public health through a robust legal and regulatory framework, ensuring that only safe, effective and quality medicines were available in Nigeria.

“One of the agency’s key initiatives is the Clean Report of Inspection and Analysis (CRIA) Scheme which ensures that medicines from high-risk countries such as China and India, meet the required quality standards before being exported to Nigeria.

“This policy, in place since 2002 and strengthened in 2020, ensures that medicines imported into Nigeria meet the highest standards.

“A key component of this process is the submission of the Certificate of Pharmaceutical Products (CoPP), a document that verifies that a consignment of medicines has undergone thorough quality checks by the regulatory authority of the exporting country.

ALSO READ:  Juventus Slump To Defeat At Empoli After Points Deduction

“Developed by WHO, the CoPP provides assurance that medicines comply with Good Manufacturing Practices (GMP) and meet safety, quality, and efficacy requirements.”

Adeyeye clarified that the manufacturer of the Rifampicin consignment had failed to provide the necessary CoPP documentation, a critical part of the importation process.

“To address that, WHO requested a waiver for the required documentation, which NAFDAC reviewed.

“Upon receiving the appeal, NAFDAC requested a laboratory evaluation of the Rifampicin consignment from one of its approved CRIA laboratories in India to ensure the product met the necessary quality, safety, and efficacy standards.

“Following satisfactory laboratory results, assurances, and the need to replenish the stock of the medicine for Nigerian patients, NAFDAC granted approval for the Rifampicin shipment to be exported to Nigeria.”

Additionally, Adeyeye stated that NAFDAC was collaborating with local pharmaceutical industries to reduce Nigeria’s dependence on imported medicines.

She said that the agency was strengthening regulatory systems and building local manufacturing capacity to ensure that quality medicines were available in Nigeria.

Adeyeye reassured the public that NAFDAC would continue to ensure the availability of only safe, efficacious, and quality medicines for distribution, sale, and use within Nigeria.(NAN)

Continue Reading

Health

NCDC confirms new Lassa fever case, calls for enhanced surveillance

Published

on

The Nigeria Centre for Disease Control and Prevention (NCDC) has confirmed a new case of Lassa fever in a 31-year-old physician who had recently travelled to the United Kingdom.

NCDC Director-General, Dr Jide Idris, disclosed this in an interview with the News Agency of Nigeria (NAN) on Sunday in Abuja.

Idris stated that the patient, who was diagnosed in Ondo State, unfortunately succumbed to the disease before the test results confirming the infection were available.

Idris raised an alert on the situation, stressing the need for heightened surveillance and precautionary measures.

He emphasised that the latest case highlighted the persistent threat of Lassa fever in Nigeria and the potential for international transmission.

According to the NCDC’s latest epidemiological report, Nigeria has recorded 2,728 suspected cases and 535 confirmed cases of Lassa fever in 2025, with 98 deaths across 14 states.

“The current case fatality rate stands at 18.3 per cent, indicating the severity of the disease.

“Five states, Ondo 31 per cent, Bauchi 24 per cent, Edo 17 per cent, Taraba 16 per cent, and Ebonyi 3 per cent account for 91 per cent of all confirmed cases.

“The most affected local government areas include Owo, Akure South, Etsako West, Kirfi, Akoko South-West, Bali, Esan North-East, Bauchi, Toro, and Jalingo.”

He said that the confirmed case involved the Nigerian physician, who travelled to the UK on Feb. 19, 2025, and returned on Feb. 27, 2025.

“He was admitted to a private health facility in Ondo State with symptoms suggestive of Lassa fever.

“Samples were taken on Feb. 28, 2025, but the patient passed away on March 1, 2025, before test results were confirmed.

ALSO READ:  Juventus Slump To Defeat At Empoli After Points Deduction

“The NCDC confirmed the diagnosis of Lassa fever on March 4, 2025.

“Investigation revealed that the deceased had visited his fiancée in Edo State before his UK trip and had also met with family and friends.

“Contact tracing efforts have since been launched in both Nigeria and the UK to curb further spread of the disease.”

In response to the case, the NCDC, in collaboration with the Ondo State Ministry of Health, had intensified contact tracing, surveillance, and infection control measures.

“The agency is identifying and monitoring all potential contacts of the deceased, including family members, healthcare workers, and co-passengers on flights.

“Port Health Services are also enhancing surveillance at entry points, particularly airports, while collaboration with UK health authorities ensures cross-border tracking of potential exposures.”

Idris reiterated public health guidelines to prevent further outbreaks, urging Nigerians to maintain proper hygiene, control rodent populations, and seek early medical intervention for suspected cases.

He emphasised that Lassa fever is a viral hemorrhagic disease primarily spread through contact with food or household items contaminated by the urine, feces, or saliva of infected rodents.

“Human-to-human transmission can also occur, particularly in healthcare settings with inadequate infection prevention and control measures.

“The NCDC continues to monitor disease patterns and deploy rapid response teams to affected areas, with specialised treatment centres providing care for severe cases.

“Public awareness campaigns are ongoing, educating communities on rodent control, food safety, and early symptom reporting.

“In spite of these efforts, Lassa fever remains a significant public health challenge, with high mortality rates and the potential for international spread, as demonstrated by this recent case.” (NAN)

ALSO READ:  Veteran Nollywood actor, “Sule Suebebe”, is dead
Continue Reading

News

Takum Chieftaincy Dispute: Chamba Group Welcomes Appeal Court’s Retrial Order

Published

on

By Nahum Sule, Jalingo

The Takum Chamba Socio-cultural Development Association has welcomed the Appeal Court’s decision to order a retrial in the long-standing chieftaincy dispute between the Kuteb people and the Taraba state government, alongside the Chamba ruling clan of Takum.

In a statement on Wednesday, the group’s spokesperson, Sawariga Dauda, said the ruling—delivered on March 5, 2025, at the Appeal Court in Yola—remits Appeal No. CA/YL/120/2024 to the Taraba State High Court for a fresh trial before a new judge appointed by the state’s Chief Justice.

Dauda expressed confidence in the judicial process, stating that the Chamba people are prepared to defend their claim to the Takum throne.

“We are not worried about the Appeal Court’s decision for a retrial. We are not appealing; we are defending our position as rightful owners of the Takum chieftaincy stool,” Dauda said.

He emphasized that historical records and previous court rulings support their claim, adding that the Chamba group remains confident of another legal victory.

The ruling is the latest development in the Takum chieftaincy tussle, a dispute that has persisted for years.

The Kuteb people have continued to challenge the Chamba ruling clan’s claim to the throne, rejecting a state government-backed rotation system that would see leadership shared between the Chamba, Kuteb, and Kpanzu groups.

ALSO READ:  Kaduna agency trains 1, 416 community project managers
Continue Reading